arrow
C

Christian Sutter

Institute of Human Genetics
H指数:56
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interdisciplinary management and genetic evaluation of pediatric cancer predisposition syndromes: a retrospective cohort study

多学科管理与儿科癌症易感综合征的遗传评估:一项回顾性队列研究

2026-09-250
OAAI
Molecular characterization of mismatch repair deficient tumors in young Jordanian patients

年轻约旦患者中错配修复缺陷肿瘤的分子特征

2026-08-170
OAAI
Development and validation of a postoperative risk calculator (POP-score) for patients undergoing cardiac surgery: a retrospective cohort study

术后风险计算器(POP-score)的开发与验证:一项回顾性队列研究

2025-12-010
OA
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Prognostic Implications of Preoperative hs-cTnT in Elective Coronary Artery Bypass Grafting

术前hs-cTnT在择期冠状动脉旁路移植术中的预后意义

2025-09-010
OAAI
Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10

PTEN基因的胚系变异:在伴有孤立性10号染色体丢失的松果体区乳头状肿瘤亚型B(PTPR-B)患者中是一种常见发现

2025-03-140
OA
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology (vol 29, pg 917, 2023)

多体神经病理学提高了小儿神经肿瘤学的诊断准确性 (第29卷,917页,2023)

2023-10-240
OAAI
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome

患有li-fraumeni综合征的儿童髓母细胞瘤患者的临床结果

2023-06-285
PRE
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry (vol 180, pg 71, 2023)
2023-05-010
OA
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology

多体神经病理学可提高小儿神经肿瘤学的诊断准确性

2023-03-1650
OAAI
Original Research Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry

原始研究分子诊断可以检测可操作的目标: 儿科靶向治疗2.0注册表

2023-02-019
PRE
Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers

多基因风险评分表明女性BRCA1/2致病变异携带者乳腺癌发病的极端年龄

2022-06-277
OAAI
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets

儿科精确肿瘤学信息注册中心: 具有非常高证据目标的患者的临床结果和益处

2021-08-09128
OAAI
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers
2020-12-2919
OA
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance survey
CANCER
IF5.1
2020-06-1818
OAAI
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

150乳腺癌风险区域的精细定位确定了191可能的靶基因

2020-01-07112
OAAI
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

BRCA1和BRCA2变异的大规模多因素可能性定量分析: 支持临床变异分类的ENIGMA资源

2019-09-01102
OAAI